Our best-selling peptide combo for healing, recovery, and getting back to what you love doing
A reasonable harm reduction approach for people on cardiovascular medications includes informing healthcare providers about BPC-157 use, starting with conservative doses, monitoring blood pressure and other relevant parameters closely, watching for any changes in medication effectiveness, and being prepared to discontinue if unexpected effects emerge
Cyano-B12 is the most commonly used, and cheapest, form of B12 with no substantial evidence that other forms are more effective in improving B12 status
However, it is not recommended for use in newborns or premature infants, as neonates lack the metabolic capacity to process benzyl alcohol safely a contraindication explicitly noted in FDA guidance on benzyl alcohol toxicity in neonates
You have vision problems
*Please note that B12 will only be administered in line with clinical guidance of confirmed B12 deficiency